A Nitrated T-Cell Epitope Enhances the Antitumor Immune Response of a TOPK-Targeted Vaccine in Glioblastoma and Its Potential for Remodeling the Tumor Microenvironment
Vaccines · 10.11.2026 · 14 (11) · 968
DOI: 10.3390/vaccines14110968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 10.11.2026. Verfasst von Danni Deng und 6 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou Sci&Tech Program, Young Talent Development Plan of Changzhou Health Commission.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) remains the most lethal primary brain tumor in adults, largely due to recurrence after surgery. Cancer vaccines, which can activate a patient’s adaptive immune system against specific tumor antigens, are a promising strategy for improving outcomes in patients with GBM.
Methods
We examined the function of T-lymphokine-activated killer cell-originated protein kinase (TOPK), a candidate tumor-associated antigen, in GBM. We then constructed TOPK-NitraTh, a vaccine coupled to a nitrated T-cell epitope (NitraTh) and targeting TOPK. Its efficacy was evaluated in the GL261 orthotopic GBM model, and single-cell RNA sequencing was used to explore the underlying immune mechanisms.
Results
TOPK functioned as a tumor-promoting factor in GBM. Vaccination with TOPK-NitraTh elicited TOPK-specific adaptive immune responses and inhibited GBM progression in the GL261 orthotopic model. Exploratory single-cell RNA sequencing analysis led us to hypothesize that the NitraTh-based vaccine may reprogram macrophages potentially via the NF-κB signaling pathway, potentially contributing to the reversal of the immunosuppressive tumor microenvironment.
Conclusions
Given its ability to remodel the tumor microenvironment, the NitraTh-based vaccine represents a promising preclinical strategy for GBM treatment.
Förderung
- Changzhou Sci&Tech Program
- Young Talent Development Plan of Changzhou Health Commission
Zitieren
APA
Deng, D., Shi, Y., Wu, G., Zhang, W., Qian, Q., Tian, H., & Peng, Y. (2026). A Nitrated T-Cell Epitope Enhances the Antitumor Immune Response of a TOPK-Targeted Vaccine in Glioblastoma and Its Potential for Remodeling the Tumor Microenvironment. Vaccines, 14(11), 968. https://doi.org/10.3390/vaccines14110968
Vancouver
Deng D, Shi Y, Wu G, Zhang W, Qian Q, Tian H, et al. A Nitrated T-Cell Epitope Enhances the Antitumor Immune Response of a TOPK-Targeted Vaccine in Glioblastoma and Its Potential for Remodeling the Tumor Microenvironment. Vaccines. 2026;14(11):968. doi:10.3390/vaccines14110968
BibTeX
@article{Deng2026,
author = {Deng, Danni and Shi, Yulian and Wu, Guangpu and Zhang, Wanli and Qian, Qianqian and Tian, Hong and Peng, Ya},
title = {A Nitrated T-Cell Epitope Enhances the Antitumor Immune Response of a TOPK-Targeted Vaccine in Glioblastoma and Its Potential for Remodeling the Tumor Microenvironment},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {11},
pages = {968},
doi = {10.3390/vaccines14110968}
}
EUVIMED